TRIM47

Chr 17

tripartite motif containing 47

Also known as: GOA, RNF100

The protein functions as an E3 ubiquitin-protein ligase that mediates ubiquitination and proteasomal degradation of CYLD in the cytosol. Based on the low pLI score (0.0003) and LOEUF score (0.79), this gene appears tolerant to loss-of-function variants, with pathogenic mutations predicted to act through a gain-of-function mechanism. However, no specific disease associations or inheritance patterns have been established for TRIM47 mutations.

Summary from RefSeq, UniProt, Mechanism
0
Active trials
22
Pubs (1 yr)
14
P/LP submissions
0%
P/LP missense
0.79
LOEUF
GOF
Mechanism· predicted
Clinical SummaryTRIM47
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
14 unique Pathogenic / Likely Pathogenic· 127 VUS of 153 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.79LOEUF
pLI 0.000
Z-score 2.26
OE 0.45 (0.270.79)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.57Z-score
OE missense 0.91 (0.821.00)
284 obs / 312.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.45 (0.270.79)
00.351.4
Missense OE0.91 (0.821.00)
00.61.4
Synonymous OE0.78
01.21.6
LoF obs/exp: 9 / 19.9Missense obs/exp: 284 / 312.5Syn Z: 2.00
DN
0.75top 25%
GOF
0.84top 5%
LOF
0.2190th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

153 submitted variants in ClinVar

Classification Summary

Pathogenic13
Likely Pathogenic1
VUS127
Likely Benign5
13
Pathogenic
1
Likely Pathogenic
127
VUS
5
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
13
0
13
Likely Pathogenic
0
0
1
0
1
VUS
0
119
8
0
127
Likely Benign
0
3
0
2
5
Benign
0
0
0
0
0
Total0122222146

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TRIM47 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →